David Now Goliath? Made In China PD-1s Sought After By Multinationals
Eager For New Products As Market Evolves
From relatively little-known to high-flying, hotly pursued targets by global pharma players, Chinese domestically developed immuno-oncology drugs are ascending in both value and attractiveness, both inside China and far beyond.